High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: Experience of the French Thrombotic Microangiopathies Reference Center

Transfusion

Volumn 54, Issue 2, 2014, Pages 389-397

  Morgand, Marjolaine ^a   Buffet, Marc ^a   Busson, Marc ^a   Loiseau, Pascale ^a   Malot, Sandrine ^a   Amokrane, Kahina ^a   Fortier, Catherine ^a   London, Jonathan ^a   Bonmarchand, Guy ^a   Wynckel, Alain ^a   Provôt, François ^a   Poullin, Pascale ^a   Vanhille, Philippe ^a   Presne, Claire ^a   Bordessoule, Dominique ^a   Girault, Stéphane ^a   Delmas, Yahsou ^a   Hamidou, Mohamed ^a   Mousson, Christiane ^a   Vigneau, Cécile ^a   Lautrette, Alexandre ^a   Pourrat, Jacques ^a   Galicier, Lionel ^a   Azoulay, Elie ^a   Pène, Frédéric ^a   Mira, Jean Paul ^a   Rondeau, Eric ^a   Ojeda Uribe, Mario ^a   Charron, Dominique ^a   Maury, Eric ^a   Guidet, Bertrand ^a   Veyradier, Agnès ^a   Tamouza, Ryad ^a   Coppo, Paul ^a   more..

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; FEMALE; FRANCE; HAPLOTYPES; HUMANS; INFECTION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE; PROSPECTIVE STUDIES; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REGISTRIES; RISK FACTORS; THROMBOTIC MICROANGIOPATHIES; TOLL-LIKE RECEPTOR 9;

EID: 84894078301     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12263     Document Type: Article

References (32)

1. Coppo P, Bengoufa D, Veyradier A, Wolf M, Bussel A, Millot GA, Malot S, Heshmati F, Mira JP, Boulanger E, Galicier L, Durey-Dragon MA, Frémeaux-Bacchi V, Ramakers M, Pruna A, Bordessoule D, Gouilleux V, Scrobohaci ML, Vernant JP, Moreau D, Azoulay E, Schlemmer B, Guillevin L, Lassoued K,; Réseau d'Etude des Microangiopathies Thrombotiques de l'Adulte. Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement. Medicine (Baltimore) 2004; 83: 233-244.
2. Raife T, Atkinson B, Montgomery R, Vesely S, Friedman K,. Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients. Transfusion 2004; 44: 146-150.
3. Scully M, Yarranton H, Liesner R, Cavenagh J, Hunt B, Benjamin S, Bevan D, Mackie I, Machin S,. Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features. Br J Haematol 2008; 142: 819-826.
4. Hovinga JA, Vesely SK, Terrell DR, Lammle B, George JN,. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 2010; 115: 1500-1511; quiz 1662.
5. Matsumoto M, Bennett CL, Isonishi A, Qureshi Z, Hori Y, Hayakawa M, Yoshida Y, Yagi H, Fujimura Y,. Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from Japan. PloS ONE 2012; 7: e33029.
6. Coppo P, Busson M, Veyradier A, Wynckel A, Poullin P, Azoulay E, Galicier L, Loiseau P,; French Reference Centre for Thrombotic Microangiopathies. HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians. J Thromb Haemost 2010; 8: 856-859.
7. Scully M, Brown J, Patel R, McDonald V, Brown CJ, Machin S,. Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link. J Thromb Haemost 2010; 8: 257-262.
8. John ML, Hitzler W, Scharrer I,. The role of human leukocyte antigens as predisposing and/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura. Ann Hematol 2012; 91: 507-510.
9. Fuchs TA, Kremer Hovinga JA, Schatzberg D, Wagner DD, Lammle B,. Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood 2012; 120: 1157-1164.
10. Motto DG, Chauhan AK, Zhu G, Homeister J, Lamb CB, Desch KC, Zhang W, Tsai HM, Wagner DD, Ginsburg D,. Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest 2005; 115: 2752-2761.
11. Veyradier A, Obert B, Houllier A, Meyer D, Girma JP,. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 2001; 98: 1765-1772.
12. Coppo P, Adrie C, Azoulay E, Leleu G, Oksenhendler E, Galicier L, Le Gall JR, Bussel A, Schlemmer B,. Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU) patients? Intensive Care Med 2003; 29: 564-569.
13. Park YA, Poisson JL, McBee MT, Afenyi-Annan A,. Seasonal association of thrombotic thrombocytopenic purpura. Transfusion 2012; 52: 1530-1534.
14. Du X, Poltorak A, Wei Y, Beutler B,. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 2000; 11: 362-371.
15. Coppo P, Schwarzinger M, Buffet M, Wynckel A, Clabault K, Presne C, Poullin P, Malot S, Vanhille P, Azoulay E, Galicier L, Lemiale V, Mira JP, Ridel C, Rondeau E, Pourrat J, Girault S, Bordessoule D, Saheb S, Ramakers M, Hamidou M, Vernant JP, Guidet B, Wolf M, Veyradier A,; French Reference Center for Thrombotic Microangiopathies. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PloS ONE 2010; 5: e10208.
16. Glickman SW, Cairns CB, Otero RM, Woods CW, Tsalik EL, Langley RJ, van Velkinburgh JC, Park LP, Glickman LT, Fowler VG Jr, Kingsmore SF, Rivers EP,. Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. Acad Emerg Med 2010; 17: 383-390.
17. Ferrari S, Scheiflinger F, Rieger M, Mudde G, Wolf M, Coppo P, Girma JP, Azoulay E, Brun-Buisson C, Fakhouri F, Mira JP, Oksenhendler E, Poullin P, Rondeau E, Schleinitz N, Schlemmer B, Teboul JL, Vanhille P, Vernant JP, Meyer D, Veyradier A,; French Clinical and Biological Network on Adult Thrombotic Microangiopathies. Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, andinhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity. Blood 2007; 109: 2815-2822.
18. Stephens M, Smith NJ, Donnelly P,. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
19. Stephens M, Donnelly P,. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.
20. Schouten M, Wiersinga WJ, Levi M, van der Poll T,. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008; 83: 536-545.
21. Semeraro N, Ammollo CT, Semeraro F, Colucci M,. Sepsis, thrombosis and organ dysfunction. Thromb Res 2012; 129: 290-295.
22. El Kebir D, Jozsef L, Pan W, Wang L, Filep JG,. Bacterial DNA activates endothelial cells and promotes neutrophil adherence through TLR9 signaling. J Immunol 2009; 182: 4386-4394.
23. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ,. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464: 104-107.
24. Itagaki K, Adibnia Y, Sun S, Zhao C, Sursal T, Chen Y, Junger W, Hauser CJ,. Bacterial DNA induces pulmonary damage via TLR-9 through cross-talk with neutrophils. Shock 2011; 36: 548-552.
25. Douglas KW, Pollock KG, Young D, Catlow J, Green R,. Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: a single-institution experience. J Clin Apher 2010; 25: 47-53.
26. Park YA, Schultz EF, Hay SN, Brecher ME,. Thrombotic thrombocytopenic purpura and urinary tract infections: is there a connection? Am J Clin Pathol 2011; 135: 85-88.
27. Howard MA, Williams LA, Terrell DR, Duvall D, Vesely SK, George JN,. Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 2006; 46: 154-156.
28. Creager AJ, Brecher ME, Bandarenko N,. Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infection. Transfusion 1998; 38: 419-423.
29. Cserti CM, Landaw S, Uhl L,. Do infections provoke exacerbations and relapses of thrombotic thrombocytopenic purpura? J Clin Apher 2007; 22: 21-25.
30. Illoh OC,. Infection as a cause of early relapse in patients recovering from thrombotic thrombocytopenic purpura. J Clin Apher 2007; 22: 204-209.
31. Karpac CA, Li X, Terrell DR, Kremer Hovinga JA, Lämmle B, Vesely SK, George JN,. Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol 2008; 141: 696-707.
32. Booth KK, Terrell DR, Vesely SK, George JN,. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol 2011; 86: 743-751.